KORU Medical Systems Free Cash Flow (FCF) History (KRMD)
KORU Medical Systems reported −$470,112 in free cash flow for fiscal 2025, an increase of $1.1M from the previous fiscal year, with a free cash flow margin of −1.14%.
View full KORU Medical Systems company overviewKORU Medical Systems free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$470,112 | $1.1M | — | −1.14% |
| 2024 | 2024-12-31 | −$1.6M | $4.1M | — | −4.81% |
| 2023 | 2023-12-31 | −$5.7M | $2.5M | — | −19.90% |
| 2022 | 2022-12-31 | −$8.2M | −$3.5M | — | −29.27% |
| 2021 | 2021-12-31 | −$4.7M | −$3.0M | — | −19.86% |
| 2020 | 2020-12-31 | −$1.7M | −$1.8M | — | −6.88% |
| 2019 | 2019-12-31 | $119,446 | −$1.1M | −89.90% | +0.52% |
| 2018 | 2018-12-31 | $1.2M | $420,549 | +55.18% | +6.81% |
| 2017 | 2017-12-31 | $762,095 | — | — | +5.72% |
| 2016 | 2017-02-28 | −$534,741 | −$2.3M | — | −4.35% |
| 2015 | 2016-02-29 | $1.8M | $1.6M | +664.01% | +14.64% |
| 2014 | 2015-02-28 | $234,686 | −$531,016 | −69.35% | +2.09% |
| 2013 | 2014-02-28 | $765,702 | $544,479 | +246.12% | +8.80% |
| 2012 | 2013-02-28 | $221,223 | −$103,143 | −31.80% | +2.85% |
| 2011 | 2012-02-29 | $324,366 | −$503,577 | −60.82% | +5.08% |
| 2010 | 2011-02-28 | $827,943 | — | — | +16.83% |
KORU Medical Systems quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $108,206 | $597,360 | — | +0.90% |
| Q1 2026 | 2026-03-31 | −$31,500 | $649,405 | — | −0.27% |
| Q4 2025 | 2025-12-31 | $686,974 | −$209,074 | −23.33% | +6.31% |
| Q3 2025 | 2025-09-30 | $12,973 | $2.0M | — | +0.12% |
| Q2 2025 | 2025-06-30 | −$489,154 | −$376,205 | — | −4.80% |
| Q1 2025 | 2025-03-31 | −$680,905 | −$201,102 | — | −7.07% |
| Q4 2024 | 2024-12-31 | $896,048 | −$4,705 | −0.52% | +10.14% |
| Q3 2024 | 2024-09-30 | −$2.0M | −$621,086 | — | −24.54% |
| Q2 2024 | 2024-06-30 | −$112,949 | $143,629 | — | −1.34% |
| Q1 2024 | 2024-03-31 | −$479,803 | $4.5M | — | −5.85% |
| Q4 2023 | 2023-12-31 | $900,753 | −$216,348 | −19.37% | +12.53% |
| Q3 2023 | 2023-09-30 | −$1.4M | $1.4M | — | −19.80% |
| Q2 2023 | 2023-06-30 | −$256,578 | $3.8M | — | −3.70% |
| Q1 2023 | 2023-03-31 | −$4.9M | −$2.4M | — | −66.73% |
| Q4 2022 | 2022-12-31 | $1.1M | $1.9M | — | +15.21% |
| Q3 2022 | 2022-09-30 | −$2.7M | −$1.8M | — | −35.33% |
| Q2 2022 | 2022-06-30 | −$4.0M | −$3.8M | — | −61.67% |
| Q1 2022 | 2022-03-31 | −$2.5M | $198,150 | — | −40.08% |
| Q4 2021 | 2021-12-31 | −$761,590 | $962,451 | — | −11.73% |
| Q3 2021 | 2021-09-30 | −$975,725 | $1.3M | — | −16.15% |
| Q2 2021 | 2021-06-30 | −$227,243 | −$2.5M | — | −4.11% |
| Q1 2021 | 2021-03-31 | −$2.7M | −$2.8M | — | −49.74% |
| Q4 2020 | 2020-12-31 | −$1.7M | −$2.5M | — | −42.49% |
| Q3 2020 | 2020-09-30 | −$2.3M | −$3.2M | — | −37.56% |
| Q2 2020 | 2020-06-30 | $2.3M | $2.8M | — | +29.71% |
| Q1 2020 | 2020-03-31 | $53,645 | $1.1M | — | +0.85% |
| Q4 2019 | 2019-12-31 | $779,653 | $761,902 | +4292.16% | +12.53% |
| Q3 2019 | 2019-09-30 | $890,781 | $588,490 | +194.68% | +13.46% |
| Q2 2019 | 2019-06-30 | −$464,129 | −$1.3M | — | −8.68% |
| Q1 2019 | 2019-03-31 | −$1.1M | −$1.1M | — | −21.85% |
| Q4 2018 | 2018-12-31 | $17,751 | — | — | +0.42% |
| Q3 2018 | 2018-09-30 | $302,291 | — | — | +6.65% |
| Q2 2018 | 2018-06-30 | $879,861 | — | — | +19.54% |
| Q1 2018 | 2018-03-31 | −$17,259 | −$98,184 | — | −0.43% |
| Q1 2017 · Mar 31 | 2017-03-31 | $80,925 | — | — | +2.22% |
| Q3 2016 | 2016-11-30 | −$411,678 | −$615,218 | — | −12.89% |
| Q2 2016 · Aug 31 | 2016-08-31 | $597,020 | −$57,345 | −8.76% | +18.97% |
| Q1 2016 · Jun 30 | 2016-06-30 | −$301,856 | — | — | −10.80% |
| Q1 2016 · May 31 | 2016-05-31 | −$316,830 | −$266,587 | — | −10.60% |
| Q4 2015 | 2016-02-29 | $985,369 | $590,810 | +149.74% | +29.81% |
| Q3 2015 | 2015-11-30 | $203,540 | $185,842 | +1050.07% | +6.47% |
| Q2 2015 | 2015-08-31 | $654,365 | $1.0M | — | +20.67% |
| Q1 2015 | 2015-05-31 | −$50,243 | −$224,506 | — | −1.91% |
| Q4 2014 | 2015-02-28 | $394,559 | $81,051 | +25.85% | +11.44% |
| Q3 2014 | 2014-11-30 | $17,698 | −$69,493 | −79.70% | +0.67% |
| Q2 2014 | 2014-08-31 | −$351,834 | −$570,648 | — | −14.05% |
| Q1 2014 | 2014-05-31 | $174,263 | $28,074 | +19.20% | +6.61% |
| Q4 2013 | 2014-02-28 | $313,508 | $51,171 | +19.51% | +11.90% |
| Q3 2013 | 2013-11-30 | $87,191 | $77,997 | +848.35% | +4.00% |
| Q2 2013 | 2013-08-31 | $218,814 | $250,032 | — | +10.90% |
| Q1 2013 | 2013-05-31 | $146,189 | $165,279 | — | +7.79% |
| Q4 2012 | 2013-02-28 | $262,337 | −$7,122 | −2.64% | +13.13% |
| Q3 2012 | 2012-11-30 | $9,194 | $37,399 | — | +0.44% |
| Q2 2012 | 2012-08-31 | −$31,218 | $200,829 | — | −1.60% |
| Q1 2012 | 2012-05-31 | −$19,090 | −$334,249 | — | −1.09% |
| Q4 2011 | 2012-02-29 | $269,459 | — | — | +13.25% |
| Q3 2011 | 2011-11-30 | −$28,205 | −$379,306 | — | −1.88% |
| Q2 2011 | 2011-08-31 | −$232,047 | — | — | −17.03% |
| Q1 2011 | 2011-05-31 | $315,159 | — | — | +21.10% |
| Q3 2010 | 2010-11-30 | $351,101 | — | — | +27.99% |
KORU Medical Systems free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$1.7M to −$470,112, a net increase of $1.2M. KORU Medical Systems's latest reported quarter, Q2 2026, generated $108,206 in free cash flow, an increase of $597,360 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review KORU Medical Systems source filings ↗